Evaluation of the Efficacy and Safety of 3D Printing for Orbital Surgery.

NCT ID: NCT04662190

Last Updated: 2025-01-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-07-05

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a multicentric, randomized, single-blinded clinical trial to evaluate the efficacy and safety of 3D printing for the planification and simulation of orbital decompression surgery for thyroid-associated orbitopathy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Thyroid Associated Ophthalmopathy Surgical Procedure, Unspecified

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control grup

Conventional surgery.

Group Type ACTIVE_COMPARATOR

Standard surgery

Intervention Type PROCEDURE

Orbital decompression surgery will be previously planned and simulated using the actual standard methods.

Intervention group

Surgery planned, simulated and guided by 3D printing.

Group Type EXPERIMENTAL

3D printing model/guide.

Intervention Type DEVICE

Orbital decompression surgery will be previously planned and simulated using 3D-printed individualized models. In the operating room, surgery will be assisted with 3D-printed individualized guides.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

3D printing model/guide.

Orbital decompression surgery will be previously planned and simulated using 3D-printed individualized models. In the operating room, surgery will be assisted with 3D-printed individualized guides.

Intervention Type DEVICE

Standard surgery

Orbital decompression surgery will be previously planned and simulated using the actual standard methods.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of inactive thyroid-associated orbitopathy requiring bilateral orbital decompression (moderate-severe in EUGOGO classification).
* Volunteers older than 18 years old.
* Ability to read.
* Acceptation to participate and signature of informed consent.

Exclusion Criteria

* Younger than 18 years old.
* Previous orbital surgery.
* Any coexisting disease preventing follow-up.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Societat Catalana d'Oftalmologia

UNKNOWN

Sponsor Role collaborator

Althaia Xarxa Assistencial Universitària de Manresa

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Eduard Pedemonte-Sarrias

Ophthalmologist, MD, PhD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Eduard Pedemonte-Sarrias, Md, PhD

Role: PRINCIPAL_INVESTIGATOR

Althaia Xarxa Assistencial Universitària de Manresa

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Eduard Pedemonte Sarrias

Manresa, Barcelona, Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Eduard Pedemonte-Sarrias, MD, PhD

Role: CONTACT

+34678091233

Anna Arnau, PhD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Anna Arnau Bartés, PhD

Role: primary

+34 93 875 93 00 ext. 3414

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CEI 20-16

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

MicroPulse TLT - UK Study
NCT05593354 NOT_YET_RECRUITING